CYPHERPUNK TECHNOLOGIES INC. Financing Cash Flow
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Financing Cash Flow of $18.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $13.17M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $5.08M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $107.95M, a 103698.08% increase year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$121.00K.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2025 was $107.65M, a 189.50% increase from fiscal 2024.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2024 was $37.18M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2023 was -$30.00K.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) financing activities for fiscal 2022 was -$210.00K, a 100.21% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $18.24M 10-Q · filed 2026-08-12 | $126.19M derived: sum of 3 quarters · filed 2026-08-12 | $126.07M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $5.08M 10-Q · filed 2026-05-14 | $113.03M derived: sum of 2 quarters · filed 2026-05-14 | $112.90M derived: sum of 3 quarters · filed 2026-05-14 | $112.78M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $107.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $107.83M derived: sum of 2 quarters · filed 2026-03-16 | $107.71M derived: sum of 3 quarters · filed 2026-08-12 | $107.65M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$240.00K derived: sum of 2 quarters · filed 2026-08-12 | -$301.00K 10-Q · filed 2025-11-12 | -$197.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$180.00K 10-Q · filed 2026-08-12 | -$76.00K derived: sum of 3 quarters · filed 2026-08-12 | -$142.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$61.00K 10-Q · filed 2026-05-14 | $43.00K derived: sum of 2 quarters · filed 2026-05-14 | -$23.00K derived: sum of 3 quarters · filed 2026-05-14 | $37.09M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $38.00K derived: sum of 2 quarters · filed 2026-03-16 | $37.16M derived: sum of 3 quarters · filed 2026-03-16 | $37.18M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $37.05M derived: sum of 2 quarters · filed 2025-11-12 | $37.08M 10-Q · filed 2025-11-12 | $37.08M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $37.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $37.15M 10-Q · filed 2025-08-14 | $37.15M derived: sum of 3 quarters · filed 2025-08-14 | $37.15M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-13 | $29.00K derived: sum of 2 quarters · filed 2025-05-13 | $28.00K derived: sum of 3 quarters · filed 2025-05-13 | $28.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$1.00K derived: sum of 2 quarters · filed 2025-03-26 | -$1.00K derived: sum of 3 quarters · filed 2025-03-26 | -$30.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.00K derived: sum of 2 quarters · filed 2024-11-13 | -$30.00K 10-Q · filed 2024-11-13 | -$30.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$29.00K 10-Q · filed 2024-08-12 | -$29.00K derived: sum of 3 quarters · filed 2024-08-12 | -$29.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$29.00K 10-Q · filed 2024-05-13 | -$29.00K derived: sum of 2 quarters · filed 2024-05-13 | -$29.00K derived: sum of 3 quarters · filed 2024-05-13 | -$29.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $0.00 derived: sum of 2 quarters · filed 2024-03-18 | $0.00 derived: sum of 3 quarters · filed 2024-03-18 | -$210.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | -$210.00K 10-Q · filed 2023-11-13 | $545.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$210.00K 10-Q · filed 2023-08-14 | $545.00K derived: sum of 3 quarters · filed 2023-08-14 | $97.81M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$210.00K 10-Q · filed 2023-05-15 | $545.00K derived: sum of 2 quarters · filed 2023-05-15 | $97.81M derived: sum of 3 quarters · filed 2023-05-15 | $97.81M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $755.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $98.02M derived: sum of 2 quarters · filed 2023-03-24 | $98.02M derived: sum of 3 quarters · filed 2023-03-24 | $98.03M 10-K · filed 2023-03-24 |
| 2021-09-30 | $97.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $97.27M derived: sum of 2 quarters · filed 2022-11-14 | $97.28M 10-Q · filed 2022-11-14 | $97.28M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $18.00K 10-Q · filed 2022-08-12 | $18.00K derived: sum of 3 quarters · filed 2022-08-12 | -$367.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-13 | $14.00K derived: sum of 2 quarters · filed 2022-05-13 | -$371.00K derived: sum of 3 quarters · filed 2022-05-13 | $48.41M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$385.00K derived: sum of 2 quarters · filed 2022-03-11 | $48.39M derived: sum of 3 quarters · filed 2022-03-11 | $74.00M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$385.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $48.39M derived: sum of 2 quarters · filed 2021-11-12 | $74.00M 10-Q · filed 2021-11-12 | $73.98M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $48.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $74.38M 10-Q · filed 2021-08-13 | $74.36M derived: sum of 3 quarters · filed 2021-08-13 | $75.62M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $25.61M 10-Q · filed 2021-05-14 | $25.59M derived: sum of 2 quarters · filed 2021-05-14 | $26.84M derived: sum of 3 quarters · filed 2021-05-14 | $28.10M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.24M derived: sum of 2 quarters · filed 2021-03-12 | $2.50M derived: sum of 3 quarters · filed 2021-03-12 | $14.82M 10-K · filed 2021-03-12 |
| 2019-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $2.51M derived: sum of 2 quarters · filed 2020-11-12 | $14.84M 10-Q · filed 2020-11-12 | $14.80M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $13.58M 10-Q · filed 2020-08-13 | $13.54M derived: sum of 3 quarters · filed 2020-08-13 | $13.47M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $12.32M 10-Q · filed 2020-05-14 | $12.28M derived: sum of 2 quarters · filed 2020-05-14 | $12.21M derived: sum of 3 quarters · filed 2020-05-14 | $13.22M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$107.00K derived: sum of 2 quarters · filed 2020-03-16 | $901.00K derived: sum of 3 quarters · filed 2020-03-16 | $15.91M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $941.00K derived: sum of 2 quarters · filed 2019-11-14 | $15.95M 10-Q · filed 2019-11-14 | $33.84M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $16.01M 10-Q · filed 2019-08-09 | $33.91M derived: sum of 3 quarters · filed 2019-08-09 | $33.91M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $15.01M 10-Q · filed 2019-05-15 | $32.90M derived: sum of 2 quarters · filed 2019-05-15 | $32.90M derived: sum of 3 quarters · filed 2019-05-15 | $32.92M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $17.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $17.89M derived: sum of 2 quarters · filed 2019-04-01 | $17.91M derived: sum of 3 quarters · filed 2019-04-01 | $47.76M 10-K · filed 2019-04-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $20.00K derived: sum of 2 quarters · filed 2018-11-09 | $29.87M 10-Q · filed 2018-11-09 | $36.59M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $20.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-08 | $29.87M 10-Q · filed 2018-08-08 | $36.59M derived: sum of 3 quarters · filed 2018-08-08 | $42.59M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $29.85M 10-Q/A · filed 2018-08-08 | $36.57M derived: sum of 2 quarters · filed 2018-08-08 | $42.57M derived: sum of 3 quarters · filed 2018-08-08 | |
| 2016-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $12.72M derived: sum of 2 quarters · filed 2018-02-23 | $25.62M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $18.90M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $12.90M 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |